Fancy a Black Friday R&D deal? Astellas has you covered

Japanese pharma Astellas is looking to offload a series of unwanted research projects ahead of Thanksgiving; if you want one, it’s made it very easy for you.

In what is an unusual move, it’s listed its more than half-dozen assets it has killed off internally under an online form called: "Contact for Potential Acquisition of Astellas’ R&D programs," and, if you like what you see, simply register your interest (and presumably have a few million dollars to hand).